HSV-2 type-specific immunoassays using glycoprotein G2 peptides
US7267940B2 · kind B2 · utility
6Cited by
9References
60Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 2003 |
| Grant date | Sep 11, 2007 |
| Priority date | — |
| Expiry date | Jan 21, 2024 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/035
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to peptides that are derived from HSV-2 glycoprotein G2 and represent HSV-2 type-specific epitopes. The present invention also provides for compositions comprising these peptides for type-specific serological diagnosis of HSV-2 infection. Methods of using these peptides for type-specific detection of HSV-2 antibodies and differentiation of HSV-2 viral infection from HSV-1 and other herpes family viral infections are further provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.